Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolai V Naoumov

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|June 7, 2002
SEN viruses and treatment response in chronic hepatitis C virusNikolai V Naoumov
Clinical Medicine (London, England)|August 28, 2002
Assessment and management of chronic hepatitis BNikolai V Naoumov
Journal of Hepatology|July 23, 2014
Cyclophilin inhibition as potential therapy for liver diseasesNikolai V Naoumov
European Journal of Gastroenterology & Hepatology|March 16, 2006
Individualization of antiviral treatment regimens for chronic hepatitis CEmma Paulon, Nikolai V Naoumov
Journal of Hepatology|June 25, 2003
Translation of immunological knowledge into better treatments of chronic hepatitis BAntonio Bertoletti, Nikolai V Naoumov
Journal of Hepatology|January 24, 2007
Immunological techniques in viral hepatitisBarbara Rehermann, Nikolai V Naoumov
Methods in Molecular Medicine|February 6, 2004
In vitro analysis of hepatitis B virus specific CD4+ T cellsShilpa Chokshi, Nikolai V Naoumov
Journal of Hepatology|January 5, 2005
The potential of RNA interference as a tool in the management of viral hepatitisJohn A Taylor, Nikolai V Naoumov
The Lancet. Infectious Diseases|April 28, 2005
Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?Ioannis Pachiadakis, Gabriele Pollara, Benjamin M Chain, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 29, 2007
Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg lossR Bridget Ferns, Nikolai V Naoumov, Richard J Gilson, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|June 7, 2002
SEN viruses and treatment response in chronic hepatitis C virusNikolai V Naoumov
Clinical Medicine (London, England)|August 28, 2002
Assessment and management of chronic hepatitis BNikolai V Naoumov
Journal of Hepatology|July 23, 2014
Cyclophilin inhibition as potential therapy for liver diseasesNikolai V Naoumov
European Journal of Gastroenterology & Hepatology|March 16, 2006
Individualization of antiviral treatment regimens for chronic hepatitis CEmma Paulon, Nikolai V Naoumov
Journal of Hepatology|June 25, 2003
Translation of immunological knowledge into better treatments of chronic hepatitis BAntonio Bertoletti, Nikolai V Naoumov
Journal of Hepatology|January 24, 2007
Immunological techniques in viral hepatitisBarbara Rehermann, Nikolai V Naoumov
Methods in Molecular Medicine|February 6, 2004
In vitro analysis of hepatitis B virus specific CD4+ T cellsShilpa Chokshi, Nikolai V Naoumov
Journal of Hepatology|January 5, 2005
The potential of RNA interference as a tool in the management of viral hepatitisJohn A Taylor, Nikolai V Naoumov
The Lancet. Infectious Diseases|April 28, 2005
Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?Ioannis Pachiadakis, Gabriele Pollara, Benjamin M Chain, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 29, 2007
Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg lossR Bridget Ferns, Nikolai V Naoumov, Richard J Gilson, et al.
Pageof 6